{"groups":[{"description":"Patients receive oral methylphenidate extended-release once daily for 7-42 days in the absence of unacceptable toxicity.","id":"FG000","title":"Arm I - Methylphenidate Hydrochloride"},{"description":"Patients receive oral modafinil once daily for 7-42 days in the absence of unacceptable toxicity.","id":"FG001","title":"Arm II -Modafinil"},{"description":"Patients receive oral placebo once daily for 7-42 days in the absence of unacceptable toxicity.","id":"FG002","title":"Arm III Placebo"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}